Web NewDrugInformation.com

Doxil Drug - Doxil The trade name of the product as shown on the labeling. Dosage - INJECTABLE, LIPOSOMAL; INJECTION The product dosage form and route separated by a semi-colon. Active Ingredient(s) - Doxorubicin Hydrochloride Multiple ingredients are in alphabetical order. Strength - 2MG/ML The potency of the active ingredient(s), Doxorubicin Hydrochloride. May repeat for multiple part products. Applicant - ALZA The firm name holding legal responsibility for Doxil. The firm name is condensed to a maximum twenty character unique string. New Drug Application (NDA) Number - 050718 The FDA assigned number to Doxil. Format is nnnnnn. Product Number - 001 The FDA assigned number to identify Doxil. Each strength is a separate product. May repeat for multiple part products. Format is nnn. Therapeutic Equivalence (TE) Code - The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products. Approval Date - Nov 17, 1995 The date Doxil was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982". Reference Listed Drug (RLD) - Yes The pioneer or innovator of Doxil. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No. Type - RX The group or category of approved drugs Doxil is in. Format is RX, OTC, DISCN. Applicant Full Name - Alza Corp The full name of the firm holding legal responsibility for the new application of Doxil. Doxil Doxepin Hcl Eq 10mg Base/ml Concentrate; Oral Doxepin Hcl Eq 10mg Base/ml Concentrate; Oral Doxepin Hcl Eq 10mg Base/ml Concentrate; Oral Doxepin Hcl Eq 10mg Base/ml Concentrate; Oral Sinequan Eq 10mg Base/ml Concentrate; Oral Zonalon 5% Cream; Topical Hectorol 0.5ugm Capsule; Oral Hectorol 2.5ugm Capsule; Oral Hectorol 2ugm/ml Injectable; Injection Doxil 2mg/ml Injectable, Liposomal; Injection NewDrugInformation